Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 46–60 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3597 CDC73 Gene Familial Parathyroid Adenoma with Cystic Changes Genetic Test This test evaluates the CDC73 gene for germline mutations associated with familial parathyroid adenoma with cystic changes, hyperparathyroidism-jaw tumor syndrome, and parathyroid...	Peripheral whole blood or FTA card (DNA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDC73 gene mutations", "Germline variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected familial parathyroid adenoma with cystic changes", "Suspected hyperparathyroidism-jaw tumor syndrome", "Suspected parathyroid carcinoma", "Family history of CDC73-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E21.0, D44.2, Z14.8 Clinical summary This test evaluates the CDC73 gene for germline mutations associated with familial parathyroid adenoma with cystic changes, hyperparathyroidism-jaw tumor syndrome, and parathyroid carcinoma.
TEST-2708 CDKN1C Gene IMAGE Syndrome Genetic Test This test analyzes the entire coding region of the CDKN1C gene using NGS to identify pathogenic variants associated with IMAGE syndrome.	Whole blood (EDTA), FTA card blood spot, or extracted genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKN1C gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected IMAGE syndrome", "Pediatric dysmorphology work-up", "Neonatal growth restriction", "Family history of IMAGE syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 93360-0 ICD-10: Q87.8 Clinical summary This test analyzes the entire coding region of the CDKN1C gene using NGS to identify pathogenic variants associated with IMAGE syndrome.
TEST-2550 CENPJ Gene (MCPH6) Genetic Test This test identifies pathogenic variants in the CENPJ gene, confirming a diagnosis of autosomal recessive primary microcephaly type 6 (MCPH6).	Blood / FTA Card / Extracted DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CENPJ gene"] Parameters [] Preparation [] Indications ["Diagnosis of autosomal recessive primary microcephaly type 6 (MCPH6)", "Carrier status determination", "Genetic counseling for families with MCPH6"] Measurement technique Confirm with laboratory Codes LOINC: 81265-5 ICD-10: Q02 Clinical summary This test identifies pathogenic variants in the CENPJ gene, confirming a diagnosis of autosomal recessive primary microcephaly type 6 (MCPH6).
TEST-2545 CEP135 Gene Sequencing for Autosomal Recessive Primary Microcephaly Type 8 (MCPH8) Test This diagnostic test evaluates the CEP135 gene for pathogenic variants associated with autosomal recessive primary microcephaly type 8 (MCPH8).	Peripheral Whole Blood (3–5 mL in EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CEP135 gene", "Copy Number Variations (CNV) in CEP135"] Parameters [] Preparation ["Provide a detailed family history", "Have previous medical reports ready for genetic counseling"] Indications ["Clinical suspicion of primary microcephaly type 8", "Family history of MCPH8", "Genetic counseling for families with microcephaly"] Measurement technique Confirm with laboratory Codes LOINC: 51968-1 ICD-10: Q02 Clinical summary This diagnostic test evaluates the CEP135 gene for pathogenic variants associated with autosomal recessive primary microcephaly type 8 (MCPH8).
TEST-3687 CEP290 Gene Meckel Syndrome Type 4 Genetic Test This test detects pathogenic variants in the CEP290 gene associated with Meckel syndrome type 4.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CEP290 gene"] Parameters [] Preparation ["None specified"] Indications ["Suspected Meckel syndrome type 4", "Family history of Meckel syndrome type 4", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q61.8 Clinical summary This test detects pathogenic variants in the CEP290 gene associated with Meckel syndrome type 4.
TEST-3519 CEP290 Gene Senior-Loken Syndrome Type 6 Genetic Test This test identifies pathogenic variants in the CEP290 gene associated with Senior-Loken syndrome type 6, characterized by kidney disease and vision loss.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CEP290 gene", "Coding exons", "Intron-exon boundaries", "Conserved splice-site regions"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counseling session is mandatory", "Parental consent required for minors"] Indications ["Suspected Senior-Loken syndrome type 6", "Family history of ciliopathy", "Need for genetic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 81301-3 ICD-10: Q87.8, H35.5, Z14.8 Clinical summary This test identifies pathogenic variants in the CEP290 gene associated with Senior-Loken syndrome type 6, characterized by kidney disease and vision loss.
TEST-2540 CEP63 Gene Microcephaly Genetic Test This test evaluates the CEP63 gene for pathogenic variants associated with primary microcephaly and Seckel syndrome.	Whole Blood (2-3 mL) or Buccal Swab / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CEP63 gene", "Single nucleotide variants", "Small deletions", "Copy number changes"] Parameters [] Preparation ["No special preparation required", "Do not discontinue prescribed medication without consulting a doctor"] Indications ["Suspected autosomal recessive primary microcephaly", "Suspected Seckel syndrome", "Clinical evaluation for developmental delay or intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 55232-0 ICD-10: Q02, Q87.1 Clinical summary This test evaluates the CEP63 gene for pathogenic variants associated with primary microcephaly and Seckel syndrome.
TEST-2785 CFAP53 Gene Heterotaxy, Visceral Type 6 Genetic Test This test identifies pathogenic variants in the CFAP53 gene associated with heterotaxy syndrome.	Whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CFAP53 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Neonates and children with suspected heterotaxy syndrome", "Individuals with complex congenital heart defects", "Family history suggestive of CFAP53-related heterotaxy"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Q89.3 Clinical summary This test identifies pathogenic variants in the CFAP53 gene associated with heterotaxy syndrome.
TEST-3815 CFHR2 Gene Hemolytic Uremic Syndrome (HUS) Genetic Test This test identifies pathogenic mutations in the CFHR2 gene associated with atypical hemolytic uremic syndrome (aHUS). It uses next-generation sequencing to detect various genetic...	Whole blood (EDTA tube), extracted DNA, FTA card blood spot	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the CFHR2 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No specific medication or diet restrictions"] Indications ["Diagnosis of atypical hemolytic uremic syndrome (aHUS)", "Familial risk stratification for aHUS", "Personalised therapeutic decisions", "Eculizumab eligibility assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94293-7 ICD-10: D59.32, D59.3 Clinical summary This test identifies pathogenic mutations in the CFHR2 gene associated with atypical hemolytic uremic syndrome (aHUS). It uses next-generation sequencing to detect various genetic alterations.
TEST-4424 CITED2 Gene Atrial Septal Defect Type 8 Genetic Test This genetic test detects pathogenic variants in the CITED2 gene linked to atrial septal defect type 8 (ASD8).	Whole Blood, Oral Swab, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CITED2 gene", "Deep intronic, regulatory, and copy number variants (if ordered)"] Parameters [] Preparation ["Genetic counseling session mandatory prior to sample collection"] Indications ["Diagnosis of Atrial Septal Defect Type 8 (ASD8)", "Familial risk assessment", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q21.1 Clinical summary This genetic test detects pathogenic variants in the CITED2 gene linked to atrial septal defect type 8 (ASD8).
TEST-4679 CLCN7 Gene Osteopetrosis, Autosomal Dominant Type 1 Genetic Test This test identifies pathogenic variants in the CLCN7 gene associated with autosomal dominant osteopetrosis type 1.	Peripheral Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CLCN7 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected autosomal dominant osteopetrosis type 1", "Family history of osteopetrosis", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21660-9 ICD-10: Q78.2 Clinical summary This test identifies pathogenic variants in the CLCN7 gene associated with autosomal dominant osteopetrosis type 1.
TEST-3919 CLCNKB Gene Bartter Syndrome Type 3 Genetic Test This test evaluates the CLCNKB gene for pathogenic variants associated with Bartter syndrome type 3.	Peripheral whole blood (EDTA), extracted DNA, or FTA card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CLCNKB gene variants", "Single-nucleotide variants", "Small indels", "Copy-number changes"] Parameters [] Preparation ["No fasting required", "No medication changes required unless advised by physician"] Indications ["Suspected Bartter syndrome type 3", "Family history of Bartter syndrome", "Unexplained electrolyte abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 55189-6 ICD-10: E26.81 Clinical summary This test evaluates the CLCNKB gene for pathogenic variants associated with Bartter syndrome type 3.
TEST-2944 CLMP Gene Congenital Short-Bowel Syndrome Genetic Test This test evaluates the CLMP gene for pathogenic variants associated with congenital short-bowel syndrome.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLMP gene", "Gene coverage depth (>200x)"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Clinical suspicion of congenital short-bowel syndrome", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-3 ICD-10: Q41.9 Clinical summary This test evaluates the CLMP gene for pathogenic variants associated with congenital short-bowel syndrome.
TEST-6182 CLN5 Gene Ceroid Lipofuscinosis Neuronal Type 5 Genetic Test This test identifies pathogenic variants in the CLN5 gene associated with Neuronal Ceroid Lipofuscinosis type 5.	Peripheral Whole Blood (EDTA)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLN5 gene", "Full gene coverage via Next-Generation Sequencing"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of Neuronal Ceroid Lipofuscinosis type 5", "Family history of CLN5 disease", "Need for genetic confirmation of diagnosis", "Family planning and carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94220-4 ICD-10: E75.4 Clinical summary This test identifies pathogenic variants in the CLN5 gene associated with Neuronal Ceroid Lipofuscinosis type 5.
TEST-2891 COL2A1 Gene Czech Dysplasia Genetic Test This test evaluates the COL2A1 gene for mutations associated with Czech dysplasia, a type of skeletal dysplasia.	Peripheral whole blood or buccal swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COL2A1 gene mutations", "Copy Number Variations (CNV) in COL2A1"] Parameters [] Preparation ["No fasting required.", "Do not discontinue any medication unless advised by your doctor."] Indications ["Suspected Czech dysplasia", "Family history of spondyloepiphyseal dysplasia", "Evaluation of collagenopathies"] Measurement technique Confirm with laboratory Codes LOINC: 83096-2 ICD-10: Q77.7 Clinical summary This test evaluates the COL2A1 gene for mutations associated with Czech dysplasia, a type of skeletal dysplasia.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.